Conference Description

October 14-15, 2006
Crowne Plaza Tampa East
10221 Princess Palm Avenue
Tampa, Florida 33610
813-623-6363

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated this conference.

CME Credits: 10.25*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. more fully understand the origins of insulin resistance and type 2 Diabetes, and review studies of atherosclerosis prevention in patients with type 2 Diabetes
2. utilize appropriate first line therapies in the treatment of diabetes with the goal of targeting the various metabolic pathways in the management of hyperglycemia, thereby preventing development of complications
3. understand the role for insulin in patients with type 2 diabetes and develop strategies for initiating and adjusting therapy
4. discuss the epidemiology, diagnostic evaluation, and treatment options of thyroid nodules
5. identify surrogates of mortality in COPD and better utilize targeted patient interventions that improve patient’s outcomes
6. recognize the signs of Pulmonary Arterial Hypertension, guide appropriate evaluation and discuss the latest therapeutic options
7. more effectively manage patients with Congestive Heart Failure and Diastolic Dysfunction
8. understand the progression of atherogenesis leading from plaque formation to cardiovascular events, discuss the role of lipoprotein subclasses as well as their response to therapy and review recent lipid treatment guidelines
9. more clearly comprehend the impact of the Renin Angiotensin System in Hypertension and its role in cardiovascular disease
10. evaluate and diagnose the etiology of anemia of chronic kidney disease, understand its implications in heart failure, and guide treatment decisions based on emerging data
11. utilize evolving data and novel therapies to understand and more effectively manage patients with chronic constipation

Agenda:
Saturday, October 14, 2006

7:30-8:10 am		Registration, Continental Breakfast and Welcome
8:10-8:20		Welcome Remarks Gregg Sherman, MD
8:20-9:20		Insulin Resistance: From Impaired Glucose Tolerance to Type 2 Diabetes – Pathophysiologic Origins, Progression to Diabetes, Prevention of Atherosclerosis Patrick Boyle, MD
9:20-10:20		Treatment Early in the Time Course of Type 2 Diabetes Patrick Boyle, MD
10:20-10:40		Break
10:40-11:40		Optimizing Therapy with Insulin in Type 2 Diabetes Bresta Miranda-Palmer, MD
11:40-12:40		Thyroid nodules: Evaluation and Treatment Options John Tourtelot, MD
12:40-1:30		Lunch
1:30-2:30		Evaluating Disease Severity in COPD: The Value of Patient Centered Outcomes Tom Ferro, MD
2:30-3:30		Pulmonary Arterial Hypertension Franck F. Rahaghi, MD, MHS, FCCP
3:30-3:50		Break
3:50-4:50		Diastolic Heart Failure: Pathophysiology and Treatment Options Stuart Katz, MD

Sunday, October 15, 2006

7:30-8:20 am		Continental Breakfast and Welcome
8:20-9:10		The Lipid Hypothesis – From Plaque Formation to Cardiovascular Events: The Role of Lipid Lowering Therapy Josh Furman, MD
9:10-10:00		Hypertension – The Role of the Renin-Angiotensin System, Focus on Target Organ Damage Josh Furman, MD
10:00-10:20		Break
10:20-11:10		Anemia in Chronic Kidney Disease: Clinical Implications and Treatment Options William McClellan, Jr., MD, MPH
11:10-12:00		Paving the way to Relief in Chronic Constipation Brooks D. Cash, MD, FACP
12:00		Conference Wrap Up Gregg Sherman, MD

Faculty:
Patrick J. Boyle, MD
Professor of Medicine
University of New Mexico

Brooks D. Cash, MD, FACP
CDR, MC, USN
Chief, Gastroenterology Division and Colon Health Initiative
Associate Professor of Medicine
National Naval Medical Center

Tom Ferro, MD
Professor of Internal Medicine and Physiology
Pulmonary & Critical Care Section
McGuire VA Medical Center
Richmond, VA

Joshua Furman, MD, FACC
Mount Sinai Medical Center
Miami Beach, Florida

Stuart David Katz, MD
Associate Professor of Medicine
Yale University School of Medicine
Director Yale Heart Failure and Heart Transplantation Program

William McClellan, Jr., MD, MPH
Professor, Department of Medicine, Division of Renal Medicine
Emory University School of Medicine

Bresta Miranda-Palmer, MD
Assistant Professor of Medicine
University of Miami
Miller School of Medicine

Franck F. Rahaghi, MD, MHS, FCCP
Director, Pulmonary Hypertension Clinic
Pulmonary and Critical Care
Cleveland Clinic Florida at Weston

John B. Tourtelot, MD, FACE, FACP
Assistant Professor of Medicine,
Department of Family Practice,
University of South Florida

Program Chair: Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 10.25 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. UMMS is accredited by ACCME to provide continuing medical education for physicians. UMMS designates this continuing medical education activity for 10.25 credit hours in Category I toward the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 12.4 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.

This program was supported through educational grants from the following companies: Abbott, Actelion, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Novo nordisk, Pfizer, sanofi-aventis, Takeda, Wyeth.